Table 2.

Relative contributions of bacteria detected by probes CF1-853 and ALF1-645 in the different second-stage vessels of the cultivation systems

TreatmentMean % (range [minimum–maximum]) of DAPI-stained bacteria with probe:
CF1-853ALF1-645
1998 19991998 1999
Ochromonas sp. 3 (<1–12)22 (3–46) 8 (4–14) 15 (4–33)
C. glaucoma 10 (3–25) 28 (7–43) 12 (5–16)19 (4–33)
Control 6 (4–8) 33 (6–55)8 (3–12) 15 (4–26)
C. glaucomaIIa 15 (7–27) 23 (11–33)
C. glaucoma II plus Ochromonassp.b 38 (28–53)12 (5–21)
  • a Before the addition of theOchromonas sp. to the C. glaucoma II treatment (days 0 to 7).

  • b After the addition of theOchromonas sp. to the C. glaucoma II treatment (days 8 to 16).